1. Barium enemas have been withdrawn

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. Keep the possibility of liver toxicity in mind with repeated halothane use

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Amoxicillin +; clavulanic acid may induce delayed cholestasis

   Newsletter Article 31 January 2013 Pages: 1 - 1

4. Pefloxacin - postmarketing surveillance in France

   Newsletter Article 31 January 2013 Pages: 2 - 2

5. ADRAC requests continued vigilance for flucloxacillin hepatitis

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Contraindication of quinolones in children should not be absolute

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Alteplase

   Newsletter Article 31 January 2013 Pages: 3 - 4

8. Anabolic steroid abuse

   Newsletter Article 31 January 2013 Pages: 4 - 4

9. Analgesic overdose

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Antidepressants/benzodiazepines/narcotics overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Antidiarrhoeal overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Aprotinin

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Bacitracin

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Baclofen abuse/interaction

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. BCG vaccine

    Newsletter Article 31 January 2013 Pages: 4 - 4

16. Benzocaine

    Newsletter Article 31 January 2013 Pages: 4 - 4

17. Benzodiazepines see Antidepressants/benzodiazepines/narcotics overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

18. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Chlorpromazine

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Cibenzoline

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Cibenzoline overdose

    Newsletter Article 31 January 2013 Pages: 5 - 6

22. Cocaine abuse

    Newsletter Article 31 January 2013 Pages: 6 - 6

23. Cotrimoxazole

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Dactinomycin/doxorubicin/vincristine

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Dapsone

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Deferoxamine

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Diamorphine

    Newsletter Article 31 January 2013 Pages: 6 - 7

28. Dinoprostone

    Newsletter Article 31 January 2013 Pages: 7 - 7

29. Doxorubicin see Dactinomycin/doxorubicin/vincristine

    Newsletter Article 31 January 2013 Pages: 7 - 7

30. Enflurane see Halothane/enflurane

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Epoetin

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. Exifone

    Newsletter Article 31 January 2013 Pages: 7 - 7

33. Furosemide

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Furosemide see Omeprazole/furosemide

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Halothane

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Halothane/enflurane

    Newsletter Article 31 January 2013 Pages: 7 - 8

37. Herbal medicines

    Newsletter Article 31 January 2013 Pages: 8 - 8

38. Insulin human

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Iohexol/ioxaglate sodium

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Ioxaglate sodium see Iohexol/ioxaglate sodium

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Isotretinoin

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Itraconazole

    Newsletter Article 31 January 2013 Pages: 8 - 8

43. Ivermectin

    Newsletter Article 31 January 2013 Pages: 8 - 8

44. Lindane

    Newsletter Article 31 January 2013 Pages: 8 - 9

45. Lithium

    Newsletter Article 31 January 2013 Pages: 9 - 9

46. Menotropins

    Newsletter Article 31 January 2013 Pages: 9 - 9

47. Methotrexate

    Newsletter Article 31 January 2013 Pages: 9 - 9

48. Methylprednisolone

    Newsletter Article 31 January 2013 Pages: 9 - 9

49. Mianserin

    Newsletter Article 31 January 2013 Pages: 9 - 9

50. Morphine

    Newsletter Article 31 January 2013 Pages: 9 - 10